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Serum albumin level is a marker of nutritive
conditions, acts as an antioxidant, and is a plasma
volume expander [1-3]. In some studies, lower serum
albumin has been regarded as an indicator of
malnutrition, inflammation, and liver disease [4], and
has been reported to be associated with increased
cardiovascular disease morbidity and mortality [4-6].
Meanwhile, other studies have not observed significant
associations between lower serum albumin and carotid
atherosclerosis [7,8]. Another study observed an
association between low serum albumin and coronary
heart disease only in current smokers, but not in never or
former smokers [9]. On the other hand, higher serum
albumin levels are linked to cardiovascular risk factors
including blood pressure and cholesterol levels [4,5,10].
In addition, some studies have reported positive
associations between serum albumin levels and
metabolic syndrome [11,12], the latter of which is a
clustering of multiple cardiovascular risk factors [13,14]. 
However, the association between serum albumin
levels and metabolic syndrome has not been established
for the Korean population. Thus, we investigated the
association between serum albumin levels and the
prevalence of metabolic syndrome along with its
components among a sample of apparently healthy
Korean adults.
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I. Participants
We performed a cross-sectional analysis of baseline
data of a community-based prospective cohort in
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Objectives: A positive association between serum albumin levels and metabolic syndrome has been reported in
observation studies, but it has not been established in the Korean population. The purpose of this study was to evaluate
the association between serum albumin levels and the presence of metabolic syndrome among a sample of apparently
healthy Korean adults.
Methods: This cross-sectional study analyzed data of 3189 community-dwelling people (1189 men and 2000 women) who
were aged 40 to 87 years and were living in a rural area in Korea. Serum albumin levels were classified into quartile
groups for each sex. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult
Treatment Panel III guidelines with an adjusted waist circumference cut-off value (90 cm for men and 85 cm for
women). An independent association between serum albumin levels and metabolic syndrome was assessed by multiple
logistic regression analysis. 
Results: Higher serum albumin levels were associated with increased prevalence of metabolic syndrome. The odds ratio
(95% confidence interval) of the prevalence of metabolic syndrome for the highest versus the lowest serum albumin
quartiles was 2.81 (1.91 to 4.14) in men and 1.96 (1.52 to 2.52) in women, after adjusting for age, smoking status, alcohol
consumption, and physical activity. When each metabolic abnormality was analyzed separately, higher serum albumin
levels were significantly associated with hypertriglyceridemia and hyperglycemia in both sexes, and with abdominal
obesity in men.
Conclusions: These results suggest that higher serum albumin levels are positively associated with an increased risk of
metabolic syndrome in Korean adults.
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Kangwha Island, South Korea. From 2006 to 2009, a
total of 3600 people participated in the baseline health
examination study. We excluded 411 participants for the
following reasons: no fasting blood sample (n=15); no
information about their smoking status and alcohol
consumption (n=5); systolic blood pressure <60 mmHg
or >300 mmHg and diastolic blood pressure <40 mmHg
or >200 mmHg (n=5); triglycerides 400 mg/dL
(n=85); history of cardiovascular disease or cancer
(n=215); aspartate aminotransferase (AST), alanine
aminotransferase (ALT), gamma glutamyl transferase
( -GTP), or creatinine levels over the 99th percentile
(n=101). Finally, 3189 participants (1189 men and 2000
women) were eligible for this study. All participants
gave written informed consents, and the study protocol
was approved by the Institutional Review Board.
II. Data Collection
The participants’ age, sex, smoking status, alcohol
consumption, physical activity, and medical history were
collected using a standardized questionnaire. The
anthropometrics including height, weight, and waist
circumference were measured. Body mass index (BMI)
was calculated as weight divided by height squared
(kg/m
2). Waist circumference was measured midway
between the inferior margin of the last rib and the iliac
crest in a horizontal plane. Blood pressure was measured
twice by an automatic sphygmomanometer (Dinamap
1846 SX/P; GE Healthcare, Waukesha, WI, USA) with
the participant in the sitting position after resting for at
least 5 minutes. If the difference between each
measurement was more than 10 mmHg, a third
measurement was performed. The mean value of the last
two measurements was used for the analysis. Blood
samples were taken after at least an 8-hour fast. Serum
levels of total protein, albumin, creatinine and Ǳ-GTP
were measured by colorimetric methods using automatic
analyzers. Serum C-reactive protein (CPR) was
measured by the turbidimetric immunoassayassay. AST,
ALT, glucose, total cholesterol, high-density lipoprotein
(HDL) cholesterol, and triglycerides were measured by
enzymatic methods. Low-density lipoprotein (LDL)
cholesterol was calculated using the Friedewald’
formula [15]. Hemoglobin A1c was measured by a high-
performance liquid chromatographic method using a
commercial kit. Fasting plasma insulin was measured by
radioimmunoassay using a commercial kit. The measure
for insulin resistance, the homeostasis model assessment
of insulin resistance (HOMA-IR), was calculated as
fasting insulin ( U/mL)fasting glucose (mg/dL)/405
[16].
III. Definition of Metabolic Syndrome
Metabolic syndrome was defined according to the
guidelines of the National Cholesterol Education Program
Adult Treatment Panel III [17] with adjustment for the
waist circumference cut-off value [18]. Metabolic
syndrome was diagnosed for participants that had any three
of the following five features: waist circumference 90
cm in men and 85 cm in women; triglycerides 150
mg/dL or on drug treatment for elevated triglycerides;
HDL cholesterol <40 mg/dL in men or <50 mg/dL in
women or on drug treatment for reduced HDL cholesterol;
systolic blood pressure 130 mmHg or diastolic blood
pressure 85 mmHg or on hypertensive drug treatment in
a patient with a history of hypertension; fasting glucose 
100 mg/dL or on drug treatment for elevated glucose. 
IV. Statistical Analyses
The mean values of the risk factors for cardiovascular
disease including blood pressure, cholesterols, and
fasting glucose were computed by quartiles of the serum
albumin level. Linear trends in these risk factors were
tested according to the serum albumin quartiles. Trends
for skewed variables were evaluated using a
nonparametric trend test. Spearman correlation analyses
were performed to assess the correlation between serum
albumin levels and other clinical characteristicts.
Logistic regression analysis was performed to assess the
association of serum albumin levels with metabolic
syndrome and also with each metabolic syndrome
component. Logistic regression analysis was performed
with and without adjustment for age, body mass index,
smoking status, alcohol consumption, and physical
activity. All statistical analyses were performed with the
SAS version 9.2 (SAS Inc., Cary, NC, USA). All tests
were two-sided and performed at a 5% significance
level.
3&46-54
Characteristics of the study participants are shown
according to the serum albumin quartiles. The
participants’ age ranged from 40 to 87 years, with a
mean age of 55.7 years. Cut-off levels for the quartile
groups were different for men and women. Thus the
analyses were performed separately for men and women
(Tables 1 and 2).  )ZF.JO$IPFUBM
+1SFW.FE1VCMJD)FBMUI	

Among the 3189 participants, a higher serum albumin
quartile level was significantly related to higher diastolic
blood pressure, total cholesterol, fasting glucose, and
HOMA-IR. We calculated the Spearman’ correlation
coefficients ( ) to assess the relationship between serum
albumin levels and each cardiovascular risk variable
(Table 3). Serum albumin levels showed a significant
(p<0.05) correlation with systolic blood pressure,
diastolic blood pressure, total cholesterol, LDL
cholesterol, triglycerides, fasting glucose, hemoglobin
A1c, HOMA-IR (in men and women), age, waist
circumference, and BMI (in men). 
Table 4 shows the association between serum albumin
quartiles and metabolic syndrome. Men with the third
and fourth quartile of serum albumin levels, and women
with the fourth quartile of serum albumin levels had a
Table 1. Characteristics of the 1189 male participants according to the quartiles of serum albumin
Variables
Serum albumin level (g/dL)
p for trend 3.1-4.3
(n=289)
4.4
(n=198)
4.5-4.6
(n=404)
4.7-5.2
(n=298)
Age (y)
Waist circumference (cm)
Body mass index (kg/m
2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Total protein (g/dL)
C-reactive protein (mg/dL) 
Aspartate aminotransferase (IU/L)
Alanine aminotransferase (IU/L)
Gamma glutamyl transferase (IU/L)
Total cholesterol (mg/dL)
HDL cholesterol (mg/dL)
LDL cholesterol (mg/dL)
Triglycerides (mg/dL)
Fasting glucose (mg/dL)
Hemoglobin A1c (%)
HOMA-IR
Metabolic syndrome
057.78.60
085.77.40
023.92.90
120.716.2
077.49.70
007.00.40
00.73 [0.39 - 1.55]
023.77.80
021.19.70
027.230.4
183.132.2
043.110.6
115.227.9
0.108 [75 - 151]
0.089 [85 - 95]
005.60.90
001.60.80
63 (21.8)
057.48.10
086.67.20
024.22.80
123.618.5
078.110.5
007.30.30
00.79 [0.39 - 1.69]
023.66.80
021.58.70
029.232.9
189.833.3
043.611.7
122.228.3
0.105 [75 - 150]
00.90 [86 - 99]
005.60.50
001.60.80
47 (23.7)
056.67.90
086.37.40
024.12.80
121.517.1
077.810.2
007.40.30
00.66 [0.39 - 1.42]
024.46.70
023.79.40
028.623.0
197.531.6
043.09.90
127.029.2
0.126 [86 - 174]
0.093 [87 - 100]
005.70.80
001.70.80
131 (32.4)
054.68.70
087.57.80
024.62.80
123.716.5
079.59.90
007.70.30
00.70 [0.40 - 1.52]
025.67.70
027.212.3
038.434.9
202.134.2
041.79.90
128.631.1
0.147 [104 - 199]
095.0 [88 - 105]
005.70.90
001.90.90
128 (43.0)
<0.001
<0.008
<0.02
<0.12
<0.02
<0.001
<0.83
1
<0.001
<0.001
<0.001
<0.001
<0.07
<0.001
<0.001
1
<0.001
1
<0.03
<0.001
<0.001
Data are expressed as meanSD, median [inter-quartile range], or number (%).
HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance.
1 Trends across quartiles of serum albumin levels were evaluated using a nonparametric trend test.
Table 2. Characteristics of the 2000 female participants according to the quartiles of serum albumin
Variables
Serum albumin level (g/dL)
p for trend 3.6 - 4.3 
(n=490)
4.4
(n=302)
4.5
(n=389)
4.6 - 5.3
(n=819)
Age (y)
Waist circumference (cm)
Body mass index (kg/m
2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Total protein (g/dL)
C-reactive protein (mg/dL) 
Aspartate aminotransferase (IU/L)
Alanine aminotransferase (IU/L)
Gamma glutamyl transferase (IU/L)
Total cholesterol (mg/dL) 
HDL cholesterol (mg/dL) 
LDL cholesterol (mg/dL) 
Triglycerides (mg/dL) 
Fasting glucose (mg/dL) 
Hemoglobin A1c (%)
HOMA-IR
Metabolic syndrome
055.28.50
087.08.70
024.73.40
119.318.4
071.910.4
007.10.40
00.64 [0.33 - 1.33]
022.66.40
019.98.70
020.122.2
186.932.1
044.310.6
119.028.3
.0102 [74 - 147]
0.089 [84 - 94]
005.60.80
001.71.30
191 (39.0)
054.98.20
087.78.50
025.03.20
117.817.9
071.29.10
007.30.30
00.67 [0.33 - 1.39]
023.16.70
021.510.5
022.120.8
194.034.0
043.69.80
125.030.7
.0114 [83 - 154]
0.091 [85 - 97]
005.70.80
001.81.20
126 (41.7)
055.28.40
087.48.10
024.63.00
118.318.3
071.910.2
007.40.30
00.69 [0.36 - 1.45]
023.06.10
021.09.60
022.522.3
203.033.5
044.610.4
131.730.4
.0120 [84 - 170]
0.090 [85 - 96]
005.70.90
001.81.10
171 (44.0)
055.28.50
087.58.50
024.93.30
121.617.7
073.710.1
007.60.30
00.69 [0.39 - 1.40]
024.07.00
023.010.4
026.426.0
205.035.0
043.710.0
132.431.8
.0129 [92 - 182]
0.093 [87 - 103]
005.81.00
001.90.90
440 (53.7)
<0.860
<0.430
<0.660
<0.030
<0.0010
<0.0010
<0.12
1  
<0.0010
<0.0010
<0.0010
<0.0010
<0.700
<0.0010
<0.001
1
<0.001
1
<0.0010
<0.0010
<0.0010
Data are expressed as meanSD, median [inter-quartile range], or number (%).
HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance.
1 Trends across quartiles of serum albumin levels were evaluated using a nonparametric trend test.4FSVN"MCVNJOBOE.FUBCPMJD4ZOESPNF
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significantly higher prevalence of metabolic syndrome
than those with the lowest quartile. Adjustment for age,
BMI, smoking status, alcohol consumption and physical
activity did not affect these associations.
We also investigated associations between serum
albumin quartiles and each of the components of
metabolic syndrome in men and women, after adjusting
for potential confounders (Table 5). Men with the third
and fourth quartiles of serum albumin levels had a
significantly increased prevalence of abdominal obesity,
hypertriglyceridemia, and hyperglycemia. Women with
serum albumin levels in the fourth quartile had an
increased prevalence of hypertriglyceridemia and
hyperglycemia, but women in the third quartile had an
increased prevalence of hypertriglyceridemia only. 
%*4$644*0/
This study showed a positive association between
serum albumin levels and the prevalence of metabolic
syndrome among a sample of apparently healthy Korean
adults even after controlling for related covariates
including age, BMI, smoking status, alcohol consumption,
and physical activity. More specifically, serum albumin
levels were significantly associated with abdominal
obesity, hypertriglyceridemia, and hyperglycemia in men,
and with hypertriglyceridemia and hyperglycemia in
women. Our findings are consistent with the Japanese
studies suggesting a positive association between serum
albumin levels and the prevalence of metabolic
syndrome [11,12]. On the other hand, other studies from
UK and the US have reported that lower serum albumin
levels were associated with an increased risk of
cardiovascular disease incidence and mortality [4-6].
The inconsistency of these findings might be, at least in
part, due to the different characteristics of the study
participants. In our study participants, higher serum
albumin levels were positively associated with most
major cardiovascular risk factors including blood
pressure, non-HDL cholesterol, hyperglycemia, and
insulin resistance. However, in the Framingham
Offspring Study, people with lower serum albumin
levels had unfavorable cardiovascular risk profiles, such
as higher BMI, total cholesterol, cigarette smoking, and
low HDL cholesterol. The inconsistency between these
study findings also might be due to different outcomes of
interest. Many studies have reported that lower serum
albumin levels increased cardiovascular disease
incidence or mortality [4-6], but the association between
serum albumin levels and carotid atherosclerosis has
been inconsistent [7,8,11]. In addition, some studies
have shown that higher serum albumin levels are linked
Table 3. Correlation between serum albumin levels
and other clinical characteristics
Men (n=1189) Women (n=2000)
p-
value
p-
value
Age (y)
Waist circumference (cm)
Body mass index (kg/m
2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Total protein (g/dL)
C-reactive protein (mg/dL)
Total cholesterol (mg/dL)
HDL cholesterol (mg/dL)
LDL cholesterol (mg/dL)
Triglycerides (mg/dL)
Fasting glucose (mg/dL)
Hemoglobin A1c (%)
HOMA-IR
-0.140
0.080
0.070
0.062
0.076
0.600
-0.007
0.234
-0.025
0.188
0.215
0.214
0.059
0.175
<0.001
<0.006
<0.02
<0.03
<0.009
<0.001
<0.80
<0.001
<0.40
<0.001
<0.001
<0.001
<0.04
<0.001
0.007
0.022
0.023
0.077
0.083
0.586
0.038
0.220
-0.013
0.176
0.184
0.184
0.090
0.168
<0.74
<0.31
<0.30
<0.001
<0.001
<0.001
<0.09
<0.001
<0.55
<0.001
<0.001
<0.001
<0.001
<0.001
, spearman correlation coefficient; HDL, high-density lipoprotein; LDL, low-
density lipoprotein; HOMA-IR, homeostasis model assessment of insulin
resistance. 
Table 4. Association between serum albumin levels and metabolic syndrome
Serum albumin level (g/dL) No. of people
No. of people with
metabolic
syndrome
Odds ratio (95% confidence Interval) 
for metabolic syndrome
Unadjusted Adjusted
1
Men 
1st quartile (3.1 - 4.3)
2nd quartile (4.4)
3rd quartile (4.5 - 4.6)
4th quartile (4.7 - 5.2)
Women
1st quartile (3.6 - 4.3)
2nd quartile (4.4)
3rd quartile (4.5)
4th quartile (4.6 - 5.3)
289
198
404
298
490
302
389
819
63
47
131
128
191
126
171
440
1.00
1.12 (0.73, 1.72)
1.72 (1.22, 2.44)
2.70 (1.88, 3.88)
1.00
1.12 (0.84, 1.50)
1.23 (0.94, 1.61)
1.82 (1.45, 2.28)
1.00
1.07 (0.68, 1.68)
1.85 (1.28, 2.67)
2.81 (1.91, 4.14)
1.00
1.11 (0.80, 1.53)
1.30 (0.96, 1.75)
1.96 (1.52, 2.52)
1 Adjusted for age, body mass index, smoking status, alcohol consumption, and physical activity. )ZF.JO$IPFUBM
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to cardiovascular risk factors [4,5,10]. These inconsistent
results suggest that low albumin levels might be a
reflection of the inflammatory process rather than an
independent risk factor of cardiovascular disease.
In our study, higher serum albumin levels were
associated with the increased prevalence of abdominal
obesity in men but not in women. Sex difference in the
association between serum albumin and abdominal
obesity can be partially explained by some mechanisms.
It is known that women have a higher amount of
subcutaneous abdominal fat and lower visceral
abdominal fat than men, and that estrogen plays a role in
this difference in fat distribution [19-22]. Albumin
synthesis is stimulated by steroids hormones [23], and
albumin acts as a carrier for steroid hormones [24]. Our
study did not observe a correlation between serum
albumin levels and CRP, while some previous studies
have reported an association between low serum
albumin levels and increased CRP [25,26]. Our study
population was limited to a sample of relatively healthy
individuals of Korea. Therefore, the association between
serum albumin levels and CRP might be diminished.
The underlying mechanisms for the association
between serum albumin levels and metabolic
abnormalities are still unclear. However, it can be
explained, at least in part, by dietary protein intake.
Protein intake has a positive association with serum
albumin levels [27-29], and high protein intake is
accompanied by the stimulation of glucagon and insulin,
high glycogen turnover, and increased gluconeogenesis
[30]. Accordingly, a high protein diet was associated
with an increased prevalence of diabetes [31,32]. Thus,
overall, high protein intake can contribute to
hyperinsulinemia, hyperglycemia, hypertension, and
lipid abnormality, and in turn can contribute to the
development of metabolic syndrome. 
This study has the following limitations. First, we did
not analyze the effects of dietary protein intake. Protein
intake can be related to both serum albumin levels and
metabolic syndrome; thus further studies are needed to
establish the underlying mechanisms of this association.
Second, we could not assess the causal relationship
between serum albumin levels and metabolic syndrome
because of the cross-sectional study design. Follow-up
studies are merited to investigate the serum albumin
levels as a prospective risk factor of metabolic
syndrome. Finally, our analysis was based on a cohort
study from one rural area and limited to relatively
healthy individuals. The findings of our study may not
be generalizable to the entire Korean population.
In conclusion, our findings suggest that higher serum
albumin levels are positively associated with metabolic
syndrome, probably through increased abdominal
obesity, high fasting blood glucose, and triglycerides.
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Table 5. Association between serum albumin levels and components of metabolic syndrome
Serum albumin level (g/dL)
Adjusted
1 odds ratio (95% confidence Interval)
Abdominal obesity High triglycerides
Low HDL
cholesterol
High blood
pressure
High fasting
glucose
Men
1st quartile (3.1 - 4.3)
2nd quartile (4.4)
3rd quartile (4.5 - 4.6)
4th quartile (4.7 - 5.2)
Women
1st quartile (3.6 - 4.3)
2nd quartile (4.4)
3rd quartile (4.5)
4th quartile (4.6 - 5.3)
1.00
1.37 (0.80, 2.34)
1.70 (1.08, 2.69)
1.89 (1.17, 3.05)
1.00
1.04 (0.70, 1.53)
1.26 (0.88, 1.82)
1.03 (0.76, 1.40)
1.00
0.99 (0.66, 1.50)
1.61 (1.16, 2.25)
2.65 (1.87, 3.78)
1.00
1.20 (0.87, 1.66)
1.55 (1.15, 2.07)
1.96 (1.53, 2.51)
1.00
0.94 (0.65, 1.36)
1.03 (0.75, 1.40)
1.16 (0.83, 1.62)
1.00
1.10 (0.78, 1.54)
0.80 (0.60, 1.08)
1.09 (0.84, 1.42)
1.00
1.00 (0.69, 1.46)
0.96 (0.70, 1.32)
1.22 (0.87, 1.72)
1.00
0.76 (0.55, 1.04)
0.82 (0.61, 1.10)
1.26 (0.99, 1.61)
1.00
1.63 (1.00, 2.54)
2.27 (1.56, 3.30)
2.80 (1.89, 4.16)
1.00
1.28 (0.89, 1.83)
1.29 (0.92, 1.80)
2.25 (1.71, 2.97)
HDL, high - density lipoprotein.
1 Adjusted for age, body mass index, smoking status, alcohol consumption, and physical activity.4FSVN"MCVNJOBOE.FUBCPMJD4ZOESPNF
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